NCT04821245

Brief Summary

The aim of this study was to describe the postoperative "baseline" magnetic resonance imaging (MRI) appearance of the ipsilateral thigh musculature after total knee arthroplasty (TKA). The secondary aim was to describe baseline muscle enzyme levels under the same clinical scenario. Neither of these measures have been reported previously.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 4, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 2, 2019

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 29, 2021

Completed
2 months until next milestone

Results Posted

Study results publicly available

May 25, 2021

Completed
Last Updated

May 25, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

March 25, 2021

Results QC Date

March 28, 2021

Last Update Submit

May 3, 2021

Conditions

Keywords

MyotoxicityMyositisMagnetic resonance imagingCreatine phosphokinaseAldolase

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Edema

    Regions of the ipsilateral thigh were defined by muscle group, neuromuscular bundle, subcutaneous tissue, or inter-muscular fascial layers. Five board-certified musculoskeletal radiologists analyzed the scans for presence of edema. Edema was considered present if judged to be so by at least 3 of the 5 radiologists.

    1-2 days postoperative

Secondary Outcomes (1)

  • Postoperative Muscle Enzyme Levels

    Sample was drawn the morning after surgery

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

* Volunteer patients of various age and sex * Number of volunteers and diagnostic studies determined by available grant monies * Volunteers were drawn from a population presenting for unilateral primary TKA performed by 1 of 2 orthopedic surgeons in a single institution

You may qualify if:

  • Scheduled for unilateral primary TKA with CACB
  • TKA and early recovery was uncomplicated (no evidence of unexpected leg weakness)

You may not qualify if:

  • Contraindication to spinal anesthesia or adductor canal-based analgesia
  • History of muscle wasting or related disease
  • History of autoimmune disorders that may affect muscles
  • History of neurologic condition affecting the lower extremities
  • Contraindications to MRI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Benaroya Research Institute

Seattle, Washington, 98101, United States

Location

Related Publications (4)

  • Neal JM, Salinas FV, Choi DS. Local Anesthetic-Induced Myotoxicity After Continuous Adductor Canal Block. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):723-727. doi: 10.1097/AAP.0000000000000466.

    PMID: 27662067BACKGROUND
  • Neal JM, Salinas FV, Choi DS. Reply to Dr Kelly et al. Reg Anesth Pain Med. 2017 May/Jun;42(3):414. doi: 10.1097/AAP.0000000000000574. No abstract available.

    PMID: 28419048BACKGROUND
  • Hussain N, McCartney CJL, Neal JM, Chippor J, Banfield L, Abdallah FW. Local anaesthetic-induced myotoxicity in regional anaesthesia: a systematic review and empirical analysis. Br J Anaesth. 2018 Oct;121(4):822-841. doi: 10.1016/j.bja.2018.05.076. Epub 2018 Aug 8.

    PMID: 30236244BACKGROUND
  • Mahyar L, Neal JM, Blackmore CC, Jackson DW, Hanson NA, MacDonald KM, Warren D, Verdin PJ. MRI and muscle enzymes do not support the diagnosis of local anesthetic myotoxicity: a descriptive case series. Reg Anesth Pain Med. 2021 Aug;46(8):679-682. doi: 10.1136/rapm-2021-102772. Epub 2021 May 31.

MeSH Terms

Conditions

MyotoxicityMyositis

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsDrug-Related Side Effects and Adverse ReactionsChemically-Induced DisordersRadiation InjuriesWounds and Injuries

Limitations and Caveats

This case series aimed to describe MRI appearance and muscle enzyme levels presented under the same clinical conditions as the 3 sentinel cases of presumed local anesthetic myotoxicity after TKA/CACB. This descriptive design was not intended to sort cause-and-effect (that is, the relative role of surgery, pneumatic tourniquet, local anesthetic, etc.) in causing muscular edema or raising enzyme levels.

Results Point of Contact

Title
Joseph M. Neal, MD
Organization
Benaroya Research Institute

Study Officials

  • Joseph M Neal, MD

    Benaroya Research Center at Virginia Mason Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Affiliate Investigator

Study Record Dates

First Submitted

March 25, 2021

First Posted

March 29, 2021

Study Start

December 4, 2018

Primary Completion

August 2, 2019

Study Completion

August 2, 2019

Last Updated

May 25, 2021

Results First Posted

May 25, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

De-identified raw data in Excel format may be obtained from Joseph M. Neal, MD upon request.

Time Frame
March 2021 through March 2026
Access Criteria
Upon request

Locations